3.

射波刀治疗31例晚期NSCLC的近期疗效以及死亡情况

Outcome and death of cyberknife for 31 patients with advanced NSCLC

Subgroup	n	RR (%)	DCR (%)	Death (%)
RR: response rate; DCR: disease control rate.
Total	31	58% (18/31)	81% (25/31)	19% (6/31)
Histology
Squamous cell carcinoma	12	58% (7/12)	75% (9/12)	17% (2/12)
Adenocarcinoma	15	47% (7/15)	80% (12/15)	27% (4/15)
Others	4	100% (4/4)	100% (4/4)	0
Gender
Male	25	64% (16/25)	80% (20/25)	20% (5/25)
Female	6	33% (2/6)	83% (5/6)	17% (1/6)
BED (Gy)
< 100	5	40% (2/5)	60% (3/5)	40% (2/5)
≥ 100	26	61.5% (16/26)	84.6 (22/26)	16% (4/26)
Total dose (Gy)
< 45	7	43% (3/7)	57% (4/7)	28% (2/7)
≥ 45	24	63% (15/24)	88% (21/24)	17% (4/24)